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 Phenyl-substituted 6H-naphtho[2,1-c]chromenes have been synthesized from 2-(3-
hydroxy-4-phenylbut-1-yn-1-yl)phenol and para-substituted benzaldehydes using a cascade of 
reactions in one pot. This cascade is mediated by BF3·OEt2 and involves an alkynyl-Prins 
cyclization, Friedel-Crafts alkylation, and aromatization through the elimination of water to 
create the final chromene product. This sequence provides up to 92% yield of white or off-white 
solids. These products express interesting photochromic activity when exposed to UV light at 
254nm, and vaguely resemble the structures of known cannabinoids. The structure of one 
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Prins Chemistry and the alkynyl-Prins Cyclization 
 The first Prins reaction (Figure 1) was reported in 1919 and involved the addition of an 
alkene to an aldehyde using a Brønsted acid.1 This reaction and its variants have been used 
extensively to construct complex natural products.1, 2 The value of this reaction comes from its 
ability to form carbon-carbon bonds as this is a fundamental process in organic chemistry.2 This 
carbon-carbon bond formation is used in both inter- and intramolecular processes, further 
emphasizing the reaction’s 
versatility. Examples of 
biologically active molecules 
synthesized with Prins 
chemistry include cyathin A3 
and (+)-neopeltolide (Figure 
2).1, 2   
One of the most significant aspects of the reaction is the formation of an oxocarbenium 
ion intermediate (Figure 3). This ion acts as an electrophile and promotes the nucleophilic 
addition of a π-bond in both inter- or intramolecular (cyclization) processes.1, 2 Computational 
studies have shown that this sp2 hybridized 
system has a preference for the E-
stereochemical configuration of attached 
Figure 2: Various natural products derived from Prins chemistry 
Figure 1: First Prins reaction 
 
Figure 3: Generic oxocarbenium ion 
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substituents.1 This orientation impacts its mechanistic activity.1 For example, the stereochemistry 
of tetrahydropyran ring systems constructed through Prins chemistry show that the E-geometry 
of the oxocarbenium ion leads to cis-products while the Z-geometry leads to trans-products in 
endo-cyclization processes (Figure 4).1 This occurs because the  substituents adapt 
pseudoequatorial orientations in the cyclohexane-like transition state.1  After  the nucleophilic 
addition of the π-bond, a carbocation is formed, which can elicit multiple other reactions.1 A 
primary issue with the Prins 
reaction is the selectivity of 
nucleophilic addition.1 This 
is usually overcome by the 
protection of reactive 
groups in previous steps or site-selective electrophile formation using a Brønsted or Lewis acid.1 
 The scope and versatility of Prins chemistry is substantial as further studies have looked 
at performing Prins chemistry with Keck allylation compounds, enol ethers, acetal molecules, 
asymmetric organometallic catalysts, and esters.1 Prins chemistry has also become a useful tool 
in the construction of isochromenes and chromenes (Figure 5).3-10 These families of compounds 
involve a conjoined ring system of an unsaturated pyran 
and aromatic rings. Depending on the saturation of these 
pyran compounds, they can be accessed using alkynes 
instead of alkenes (otherwise known as an alkynyl-Prins 
reaction).3, 4 Past research on chromenes and Prins chemistry includes generating 1H-
benzo[f]isochromenes from alkynediols with only water as a byproduct,3 investigating the 
electronic effects of an alkynyl-Prins cyclization for benzo[f]isochromenes,4 synthesizing cis- 
Figure 5: Structure and nomenclature of 
generic chromenes and isochromenes 
Figure 4: Stereochemistry of tetrahydropyran formation through Prins chemistry 
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and trans-fused hexahydropyrano[4,3-b]-chromenes,5 using Prins chemistry to construct 
octahydro-2H-chromen-4-ols,6 constructing 6H-Chromeno[3,4-b]quinoline-6-ol molecules from 
3-Nitro-2H-chromenes with Prins chemistry,7 the enantioselective synthesis of (+)-cortistatin A,8 
the total synthesis of (–)-centrolobine,9 and producing the first synthesis of a eunicellin 
diterpene.10 The biological potential of Prins chemistry is high as there have been recent 
investigations to further understand the activity of these chromene compounds as anti-HIV, anti-
tumor, antibacterial, and fungicidal agents.10 
 Prins reactions using alkynes as the nucleophilic component of the procedure, deemed an 
alkynyl-Prins reaction, are less common. This reaction’s potential has 
been overlooked in studies of methodology for Prins chemistry as it can 
access possible natural products. Previous research of the alkynyl-Prins 
cyclization performed by Hinkle and coworkers involves a cascade of 
reactions, which include nucleophilic attack by a free hydroxyl, alkynyl-
Prins cyclization, Friedel-Crafts alkylation, and dehydration, to produce 
novel tricyclic 2,4-dihydro-1H-benzo[f]isochromenes (Figure 6, 21).3 
Furthermore, Hinkle and coworkers have found that electron-donating substituents on the 
aldehyde as well as the aryl ring involved in the Friedel-Crafts step increase the efficiency of the 
reaction.4 These investigations present the cascade as an atom economical sequence as it only 
releases water as a byproduct.3, 4  
Figure 6: Generic 
example of 1H-
benzo[f]isochromenes 




 The work described herein is to further expand our 
knowledge on the synthetic capabilities of the alkynyl-Prins 
cyclization with more complex substrates. We utilized 2-(3-
hydroxy-4-phenylbut-1-yn-1-yl)phenol (4) (Figure 7) as a 
precursor along with para-substituted benzaldehydes to synthesize 
novel phenyl-substituted 6H-naptho[2,1-c]chromenes.  
Photochromic Compounds 
 Photochromic compounds are a class of molecules that proceed through reversible 
transformations, induced in one or both states by electromagnetic radiation.11 In these processes, 
compounds change their light-absorbance properties, and therefore change their perceived 
color.11 This class of compounds is very large, and it covers a diverse set of substances, 
including spiropyrans (Figure 8), spirooxazines, benzo- and napthopyrans (chromenes) (Figure 
9), fulgides, diarylethenes, dihydroindolizines, quinones, and thiazines.11 While these 
compounds are extremely varied in structure, they are 
generally complex molecules containing significant and 
extended conjugation.  
Figure 7: Structure of 2-(3-
hydroxy-4-phenylbut-1-yn-
1-yl)phenol (4) 
Figure 8: Structure of an 
indolinospiropyran, which is a 
commonly studied spiropyran 
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 These molecules are activated by absorbing light of various wavelengths which induce a 
change in chemical and electronic structure. Generally, the largest absorption bands of these 
photochromic compounds occur in the UV region and their transformations induce a shift in 
absorption to longer wavelengths.11 The majority of chemical changes occur as unimolecular 
reactions.11 Common themes in 
structural change consist of ring 
opening or ring closing 
heterocyclic compounds (Figure 
9, 10).11 Common methods of 
structural change involve 
electron movement or group 
transfer (whether substituents, 
protons, or electrons transferring).11 
Excited molecules revert back to their ground-state structure through both thermal and 
photochemical pathways.11  
 Photochromic compounds are very versatile in their utility as they can be applied to a 
multitude of electrical, 
optical, and 
commercial systems.11 
These compounds and 
their change in 
perceived color can be 
utilized both directly and indirectly. Several direct applications include variable-transmission 
Figure 10: An indolinospiropyran ring opening and a spirooxazine ring closing in 
the presence of light 
Figure 9: Naptho- and benzopyrans undergoing photochemical 
transformations to their biaryl quinone methide intermediates 
11 
 
optical materials like camera filters, fluid flow visualization, optical information storage, 
authentication systems, and novelty items like toys and cosmetics.11 Some indirect applications 
include optoelectronic systems, holographic systems, optical switches, enzymatic systems, and 
nonlinear optical devices.11 
Each family of compounds listed above has their own properties and interesting 
behaviors, but the most relevant to our work are the benzo- and napthopyrans (Figure 9). These 
families of molecules have largely been overlooked regarding their application as photochromic 
compounds.12 The first chromene was synthesized using Prins chemistry by Wizinger and 
Wenning in 1940, albeit incorrectly reported, and the photochromism of chromenes was 
investigated by Becker and Michl in 1966 with 2H-1-benzopyrans.12 Recently, research has been 
undertaken to investigate and understand both the synthesis and mechanistic properties of 
chromenes as photochromic compounds.13-18  
Beginning in the 1990’s, industry has driven research on the photochromic properties of 
benzo- and napthopyrans.12 Because of this, the majority of past research on this family of 
compounds have been used in commercial applications and their characteristics are described in 
patents.12 Nonetheless, academic interest in these substances continues for further applications.13-
18 Recent research has focused on further understanding the mechanistic pathways of 
chromenes.13-15 Some research includes exploration of the photocyclization and planarization of 
1,1’-binapthalene structures,13 investigation of 1,1’-binapthylpyran and its biaryl quinone 
methide intermediate (Figure 9) for use as a chiral photochromic optical trigger for liquid 
crystals,14 and photochemical metal complexation by a napthopyran derivative.15 In addition, 
efforts have been focused on synthesizing these families of compounds with novel and more 
efficient routes, including: (a) the lithiation of dinaphthofuran,16 (b) an inverse electron-demand 
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Diels-Alder reaction (Figure 11),17 and (c) an 
intramolecular hydroarylation/cycloisomerization 
(Figure 12).18  
Another component of this work herein is 
to synthesize possible photochromic compounds 
using the alkynyl-Prins cyclization. By constructing more substituted, novel, and complex 
biarylpyrans, we hope to further understand the synthetic, structural, and mechanistic properties 
of this family of compounds. We performed 
UV/Vis absorption and X-ray 
crystallographic experiments to better 
comprehend these families of compounds.  
Cannabinoids 
Another, longer-
term, potential application 
of intramolecular Prins 
chemistry involves 
synthesizing ring systems 
similar to those found in 
cannabinoids. 
Cannabinoids are a class of biologically active molecules that have been studied for multiple 
centuries as natural products used for medicinal purposes in both technical and traditional 
settings.19 There are multiple types of cannabinoids; the three main categories are (a) 
Figure 13: Various biologically active cannabinoids 
Figure 11: Inverse electron-demand Diels-Alder 
reaction to form chromenes 
Figure 12: Cycloisomerization reaction to form chromenes 
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endocannabinoids, (b) natural or phytocannabinoids, and (c) synthetic cannabinoids.20 
Endocannabinoids are active compounds found naturally produced in the human body like 
cannabigerol (Figure 13). Phytocannabinoids, like delta-9-tetrohydrocannabinol (also known as 
∆9-tetrahydrocannabinol) and cannabidivarin, are compounds derived mostly from the Cannabis 
sativa plant as well as other plants in the Cannabis genus. These Cannabis plants were first 
grown and used in India and the Middle East.19 Synthetic cannabinoids are synthesized 
compounds that target the endocannabinoid system like cannabilactone which was synthesized 
by Khanolkar and coworkers (Figure 13).20 
Recent research of cannabinoids has delved into their therapeutic role in medicinal 
chemistry.21-26 Specifically, past research highlights the potential of cannabinoids for their: (a) 
analgesic effects20 and (b) properties of nausea suppressant for chemotherapy.21 Furthermore, 
cannabinoids have been used with diseases like Alzheimer’s,22 multiple myeloma,23 senile 
dementia,24 epilepsy,25 and breast and prostate carcinomas.26 Cannabinoids target and bind to the 
endocannabinoid system in humans. This system consists of two G-protein-coupled receptors 
(GPCRs), CB1 and CB2. These are found as integral proteins in the cell membrane that can bind 
to cannabinoid analogues and cause biological processes to occur inside the cell.27 Only recently 
has the crystal 
structure of CB1 
(Figure 14)28 been 
mapped after 
significant research 
into active sites, 
moiety binding, as 
Figure 14: Crystal structure of CB1 
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well as recent developments to understand GPCR’s.28 After binding to the CB1 (brain) and CB2 
(spinal cord) receptors, the human body metabolizes the components and excretes them through 
the endocrine system. 
One of the most active and well-known cannabinoids is ∆9-tetrahydrocannabinol (Figure 
13). This specific isomer of tetrahydrocannabinol (THC) was the first phytocannabinoid to be 
obtained and purified through acetylation, crystallization, and hydrolyzation of an extract of the 
Cannabis sativa plant by W. R. Dunstan and T. A. Henry in 1898.19 ∆9-Tetrahydrocannabinol 
has a significantly high binding affinity for both the CB1 and 
CB2 receptors, making it a very pharmacologically active 
compound.29 Interestingly, biologically active cannabinoids 
have a diverse set of structures (Figures 13, 15). For example, 
neither nabilone or cannabigerol follow the general structure 
seen in ∆9-tetrahydrocannabinol (Figures 13, 15), but all of 
these compounds are involved in receptor binding. 
 While basic knowledge on the activity of cannabinoids has existed for a long time, 
furthering research taps into the extensive potential of these compounds.27 More research on 
cannabinoids display properties like antioxidant reactivity, anti-inflammatory responses, 
neuroprotection for neurodegeneration, anti-schizophrenic responses, antiepileptic expressions, 
sleep-promoting properties, and significant modulation effects on the immune system.30 
Research supports that CB1 receptors are mainly paired with the psychoactive effects when 
activated and expressed in the central nervous system, and CB2 receptors are associated with 
expression in the immune system.30 Several phyto- and non-natural cannabinoids still bind to 
both receptors, so there is no strong evidence of the separation in activity of each receptor.30 




Recent efforts have been focused on constructing synthetic cannabinoids which solely target 
CB2, to access its therapeutic activity with minimal side-effects. For example, Khanolkar and 
coworkers have synthesized the compound cannabilactone, and cited that its lactone structure is 
the key to binding to CB2 (Figure 13).20 
Studies have been performed with cannabinoids targeting specific diseases and disorders 
to investigate their possible pharmacology. For example, the administration of various natural 
and non-natural cannabinoids in multiple sclerosis patients led to subjective improvement in 
spasticity and muscle pain in one study, as well as improvement in mobility and decreased pain 
in another.30 These substances also affect peripheral neuropathic pathways by relieving pain in 
animal models.30 Another study advocated for cannabinoids as additives to prescribed analgesic 
medications, as they elucidated a response of relief in patients who became unresponsive to the 
prescribed analgesics.30 Cannabinoids have also shown a significant effect on the morning pain, 
sleep quality, and disease activity score of patients with arthritis or arthritic symptoms.30 There 
are multiple studies showing strong suggestions of cannabinoids creating an antiemetic effect, 
which is suppressing the urge to vomit, with chemotherapy patients.30 Cannabinoids have 
recently become more viable medicinal substances for these purposes: only two drugs containing 
cannabinoid-like structures were under development in 1995, but twenty-seven drugs with 
cannabinoid-like structures were under development in 2004.30 
By using known biologically active cannabinoids as inspiration, such as cannabidivarin 
(Figure 13), we may be able to construct structurally-related molecules with beneficial 
pharmacological effects. We hope that our synthesized compounds can possess interesting 
therapeutic effects, and we plan on sending samples of our substances to the pharmaceutical 
company Eli Lilly for testing in biological assays.  
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Results and Discussion 
Development of Synthetic Procedure 
  When we designed our synthetic investigation of using the alkynyl-Prins cyclization as 
the focal point of the procedure, our products would be more structurally distant to known 
cannabinoids than originally envisioned. The synthetic procedure was modeled after past efforts 
by Hinkle and coworkers.3, 4 Our synthetic foundation came from Δ9-tetrohydrocannabinol, as we 
envisioned an approach to this known cannabinoid through a Prins cyclization, but the desired 
starting material would require a longer synthetic sequence (Figure 16). We modulated our 
foundation to a more idealized procedure. This would incorporate an alkynyl-Prins cyclization, 
or traditional Prins chemistry depending on the desired carbon-carbon bond, to form a 
structurally similar product to Δ9-tetrohydrocannabinol. We did not pursue this product, as to 
most efficiently expand the scope of the alkynyl-Prins cyclization to cannabinoid-like structures 
Figure 16: Comparison of our synthetic foundation, idealized, and simplified procedures 
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we appended a phenyl ring on the homopropargylic alcohol of the alkyne. This simplified 
procedure gave us novel products which have minimal correlation in structure to known 
cannabinoids (Figure 16). 
 After performing more research on structurally similar products, we realized that the 
product of the simplified substrate is extremely similar to known photochromic compounds 
(Figure 9, 16). The commonality of the tetracyclic ring structure with a chromene core firmly 
connected our products to these light-sensitive compounds. Using past research on photochromic 
compounds, we were able to theorize and analyze the potential light interactions and chemical 
transformations our products would undergo (Figure 27, Page 31). This realization of structural 
similarity caused a change of perspective in our project’s purposes and goals, leading us to 
further attempt to understand the structural, mechanistic, and electronic properties of our 
possibly photochromic molecules. 
Synthesis of Starting Material 
 To access the desired chromene structures using an alkynyl-Prins cyclization, we chose to 
synthesize compound 4, 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol (Figure 7). We determined 
that this route would be the most rapid way to access potential substrates and attempt the 
alkynyl-Prins cyclization with ortho-substituted phenol compounds. To construct 4 (Figure 17), 
we began with 2-iodophenol and performed a Sonogashira coupling with trimethylsilylacetylene 
using catalytic bis(triphenylphosphine)palladium(II) chloride and copper iodide as a co-catalyst 
in triethylamine at 45°C. This provided 1 in 93% yield. Next, we deprotected the alkyne by 
removing the trimethylsilyl group with potassium fluoride in methanol to give 2 in 88% yield. 
We protected the phenol using chlorotriethylsilane in dichloromethane, obtaining 3 in 78% yield. 
18 
 
Deprotonation of the alkyne using n-butyllithium (n-BuLi) in tetrahydrofuran at –78°C formed 
the corresponding lithium acetylide. Addition of the acetylide to phenylacetaldehyde produced 4, 
2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol in a disappointing 11% yield. The key step was the 
cascade of reactions including the alkynyl-Prins cyclization, involving 4, a para-substituted 
benzaldehyde, and boron trifluoride diethyl etherate (BF3·OEt2) at –78°C. 
 This initial synthetic procedure was successful in producing pure 2-(3-hydroxy-4-
phenylbut-1-yn-1-yl)phenol (4), a white solid, but in low yield (<11% yield). The use of n-
butylithium displaced the triethylsilyl protecting group. Furthermore, the procedure was long and 
it demanded a chromatographic separation for every step as reagents like chlorotriethylsilane 
Figure 17: Initial synthetic procedure for 4 and chromene structure 
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were used in excess. After further 
efforts, we modulated this initial 
synthetic route using a tert- 
butyldimethylsilyl group (Figure 18). 
By substituting the triethylsilyl group, 
we obtained better yields in the 
deprotonation with n-butyllithium. The 
downside of this increased yield was that 
another deprotection step was needed to synthesize 4, as the tert-butyldimethylsilyl protected 
compound did not proceed through the key cascade of steps. However, the triethylsilyl protected 
compound (10) could perform the key step in low yields.  
To overcome these earlier limitations, we devised an alternate synthetic route using fewer 
steps by re-ordering the sequence of the reactions. This alternate synthetic procedure (Figure 19) 
only uses four steps to synthesize 4. It begins with deprotonation of trimethylsilylacetylene with 
n-butyllithium in tetrahydrofuran at –78°C and adding the corresponding acetylide to 
phenylacetaldehyde. This produced 7 in 60% yield. Next, the trimethylsilyl group was removed 
with potassium fluoride in methanol, generating 8 in 83% yield. To assist in a further step, 2-
iodophenol was protected as the triethylsilyl derivative in dichloromethane, producing 9 in 93% 
yield. We then coupled the triethylsilyl protected 2-iodophenol with 1-phenylbut-3-yn-2-ol (8) 
Figure 18: Adjusted synthetic procedure using a TBS group 
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using a Sonogashira coupling with catalytic palladium (II) acetate, triphenylphosphine to 
coordinate to the palladium center, and copper iodide as a co-catalyst in triethylamine. This 
coupling gave us 10, the triethylsilyl protected version of 4, in 51% yield.  
The coupling of an alkyne with a propargylic hydroxyl and an iodine has proven difficult 
for other researchers, as the palladium can induce undesired reactions regarding this propargylic 
alcohol.31 Furthermore, the collected alkynediol from this reaction was a brown oil instead of a 
white solid even though nuclear magnetic spectroscopic analysis provided identical spectra, 
Figure 19: Alternate synthetic procedure for 4 and chromene structure 
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eliciting the possibilities of complex reaction mixtures. So, while this procedure was shorter, it 
did not afford sufficient quantities of pure alkynediol starting material 4 or 10. 
 The generation of our starting materials proved to be difficult; our initial efforts had a 
longer synthetic procedure and our alternate procedure generated 10 with little purity. Therefore, 
we were not able to test as expansive of a scope as originally envisioned, but we did synthesize 
multiple products using this method (Figure 20). Due to the limited quantities of the alkynediol 
4 and 10, we were not able to 





respectively, to fully characterize 
by NMR and UV/Visible spectrophotometry. However, products 11, 12, and 13 were synthesized 
in enough quantity for characterization by NMR. 11 was synthesized in 70% yield and 12 was 
synthesized in 92% yield, but 13 was synthesized in only 1% yield on multiple occasions. 
Proposed Mechanism for the Cyclization 
 The cascade of reactions involved in the key step of this synthetic procedure has 
interesting properties in terms of mechanism and structural formation. What makes this process 
valuable is that the cascade of reactions occurs in one pot. Hinkle and coworkers proposed two 
paths for this cascade of reactions depending on complexation with the Lewis acid (Figure 21). 
Figure 20: Synthesized products using our synthetic procedure 
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Their research states that only Path B is observed, synthesizing benzo[f]isochromenes, even 
though the 5-exo-dig process commonly occurs with other internal alkyne cyclizations.3, 4 
An analogous mechanism using 4-bromobenzaldehyde as our initially formed 
electrophile along with an internal base in the system is shown below (Figure 22). First, the 
Lewis acid activates the aldehyde, promoting the addition of the phenol of 4 to form 16. The 
Lewis acid complex departs to form the oxocarbenium ion 17, which the alkyne attacks in a 6-
endo-dig process, forming the strained intermediate 18. A Friedel-Crafts alkylation occurs, 
generating the carbocation 19, and elimination of water forms the observed chromene product 
11. This pathway follows Hinkle and coworkers’ past research closely and, in a similar fashion, 
the 5-exo-dig product was not observed as the major product, but minor amounts of such 
substances may have been present in the reaction mixtures. We noted that the reactivity of the 
phenol in 4 could elicit other non-desired reactions. In past research by Hinkle and coworkers, 
the alkynediol was an alkyl hydroxyl instead of a phenol, so our substrates, given their lower 
pKa, could potentially induce other reactions in these reaction conditions.3, 4 In addition, the 
formation of a non-linear, sp-hybridized carbocation is significantly high in energy and strain. 
Figure 21: Hinkle and coworkers’ proposed mechanism 
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So, this mechanism could be rerouted to avoid this high energy intermediate and induce non-
desired byproducts. 
Figure 22: Proposed mechanism of cascade of reactions to generate our chromene products 
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So, this project did expand the scope of the alkynyl-Prins cyclization and the surrounding 
cascade of reactions by utilizing more complex substrates. Our efforts allowed us to further 
analyze both the potential of using this cascade for complex products and the downfalls of 
substrates in these reaction conditions. With this greater knowledge of the reaction, we attempt to 
further investigate this reaction. 
Synthesis and NMR Properties of Chromene Products 
 The first product we focused on synthesizing and optimizing was 11 due to the stability 
in storage and ease of handling of 4-bromobenzaldehyde. We began by using procedures similar 
to past research by Hinkle and coworkers, which describes using both the aldehyde and the 
Lewis acid (BF3·OEt2) in excess. Using this procedure, yields were low (12% yield), so we 
modulated the reaction time, the temperature of the reaction, the Lewis acid used, and the 
amount of Lewis acid. 
 Originally, we let the reaction stir overnight.3, 4 After quenching and working up the 
reaction, a significant number of other products were observed in the crude reaction mixture by 
Thin Layer Chromatography (TLC). In addition, the 1H-NMR spectra of crude reactions 
displayed undesired byproducts. We then shortened our reaction time and monitored its progress 
more closely by TLC. We observed that little to no more product was formed after 5 hours, and 
the reaction mixture became more complex. So, we began to stop our reaction around 5 hours, 
and obtained better yields of 11. 
 Another important component of the reaction conditions we changed was the 
temperature. In the original conditions by Hinkle and coworkers, the reaction mixture was 
allowed to warm to room temperature from –78°C.3, 4 When we employed these conditions, we 
25 
 
observed the creation of undesired byproducts by TLC as the temperature increased. However, 
11 was obtained in 70% yield and 12 was obtained in 92% yield with the reactions warming up 
over 5 hours. We also tested the synthesis of 11 at a constant –78°C, and we received a 49% 
yield in 5 hours. All of these observations possibly elicit that this reaction runs at a higher rate or 
more effectively at a slightly warmer temperature than –78°C. So, we could either allow a longer 
reaction time at –78°C or find a more optimal temperature for this reaction.  
 Even though Hinkle and coworkers found that BF3·OEt2 was the most effective Lewis 
acid, we also examined other acids. We employed scandium(III) triflate and BF3·OEt2 to 
investigate the effects of different reactivities of the Lewis acid. We examined the crude reaction 
mixtures and we saw little to no change in the yields of 11. So, due to availability, experience, 
and pricing, we continued using BF3·OEt2 which led to good yields of 11 and 12. 
 Another important component of the conditions in the key step is the amount of Lewis 
acid used. Hinkle and coworkers past research found that using 3.0 molar equivalents of 
BF3·OEt2 gave optimal yields in the synthesis of their desired products. 
3, 4 When we utilized this 
amount, only 12% of 11 was isolated. It is possible that our desired chromenes react with 
BF3·OEt2 in solution and degrade, especially when there is a large excess of the Lewis acid 
present. So, we modulated the procedure by using 2.0 molar equivalents of BF3·OEt2, and we 
received significantly better yields (49-70% yield) of 11. We still utilized an excess of Lewis 
acid to readily promote the aldehyde as an electrophile to allow all of the starting material (4) to 
be consumed, as well as bind to the water produced in the reaction. 
 To assist in our screening process, we employed Gas chromatography–mass spectrometry 
(GC-MS) to analyze crude reaction mixtures. Once we synthesized our desired chromene, we 
could take a sample and determine its retention time using an existing program. After 
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determining the retention time of an authentic sample of 11, we could screen a crude reaction 
mixture for our product without chromatographic separation or NMR analysis. We observed that 
11 passed through the chromatographic column around 28.77 minutes using a predetermined 
program. By analyzing a known amount of a substance in our crude reaction mixture, we were 
able to estimate yields of reactions without having to use column chromatography (Figure 23). 
We injected 10.0 µL of undecane into our reaction mixtures, which would not overlap with our 
product peak, and used a 1.0 µL sample for analysis. 
 After synthesizing our 
desired chromenes, we 
characterized them using 1H, APT, 
13C, gCOSY, and HSQC NMR 
techniques (attached in the 
Supporting Information section). 
Due to challenges synthesizing 
large quantities of starting material 4, we could only characterize 11, 12, and 13 because 14 and 
15 were obtained in small amounts. We can still analyze these spectra for structural information, 
the most fascinating of which is the 1H NMR spectra. All of our desired chromene products 
consist of mostly aromatic hydrogens and a singular, characteristic non-aromatic hydrogen, 
except 13 which contains an additional methyl group. These structures elicit complex and 
interesting coupling in the aromatic region of their 1H NMR spectra, but, given the number of 
aromatic resonances, not all were fully resolved. 
One noteworthy observation is a peak around 7.42 ppm which displays a coupling pattern 
of doublet of triplets for 11. This peak is not observed in either 12 or 13, indicating complex 
Figure 23: Sample spectrum from GC/MS showing small peak of 11 
(28.77 min.) and large peak of 4-bromobenzaldehyde (20.74 min.) 
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long-distance coupling of the aromatic hydrogens surrounding the bromine. This observation 
suggests that the bromine mediates this interesting coupling while a chlorine and methyl do not. 
The property could occur due to a combination of electron-donating, electron-withdrawing, 
resonance, and induction interactions with the bromine and the phenyl ring which the chlorine 
and the methyl cannot perform. This aromatic peak is most likely shifted upfield in both 12 and 
13, as seen in their peaks and integrations. 
Another interesting observation is the presence of the aromatic peak around 8.64 ppm in 
11, 12, and 13. Compared to other aromatic hydrogens, this is shifted significantly downfield. 
After calculations using ChemDraw and analysis of the X-ray crystal structure of 11 (Figure 24, 
Page 28), we found that the napthyl hydrogen adjacent to the pyran ring (Figure 24, Hydrogen 9) 
has this value. Most likely, this property occurs due to a complex combination of the twisted 
nature of the napthyl ring and steric compression.  
X-ray Crystallographic Analysis 
 We analyzed 11 by X-ray crystallographic analysis. This technique provides accurate 
bond lengths, bond angles, and torsional angles for crystalline compounds. With the help of Dr. 
Robert Pike and Ms. Amelia Wheaton, a Bruker SMART APEX II X-ray crystallographic 
system was used along with the program Mercury to analyze the structure of 11. Full 




The 3-dimmensional crystal structure of 11 (Figure 24) exhibits a twisting between the 
phenyl and napthyl groups surrounding the pyran core. By examining the crystallographic data, 
we found that the torsion angle of carbons 10, 11, 12, and 13 is 27.9°. Structurally similar 
compounds reported by Shi and coworkers display a respective torsion angle of 37°.13 Also, Shi 
and coworkers propose that the biaryl quinone methide intermediate of their products planarizes 
after exposure to UV light.13 While we were not able to study the planarization of our chromene 
compounds, we can investigate the structure and provide evidence for its properties. The para-
bromophenyl group is rotated 61.85° out of plane of the napthyl ring. Both of these anomalies 
derive from steric hinderance of the planar hydrogens; the primary observation stems from 
Figure 24: X-ray crystal structure of 11 from a face-on view with labels (torsion angle of interest in purple, oxygen 
in red, bromine in orange, carbon in grey, hydrogen in white)  
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hydrogens 9 and 13 and the second comes from hydrogens 3 and 23 (Figure 24, 25). The napthyl 
and phenyl groups twist in order to avoid steric interactions between hydrogens 9 and 13, 
forming a conformational energy minimum (Figure 24, 25). In a similar situation, the para-
bromophenyl group is twisted out of plane due to steric hinderance between hydrogens 3 and 23 
(Figure 24). The planar conformation of the molecule would induce a high energy conformation 
with multiple instances of eclipsing atoms. 
So, given these X-ray crystallographic experiments, it is facile to see these novel 
compounds’ unique structural properties. A motivation for the synthesis of these compounds are 
their structural and electronic properties in commercial products, and our synthesized products 
Figure 25: X-ray crystal structure of 11 from a side view to depict the torsion angle of interest (torsion angle of 
interest in purple, oxygen in red, bromine in orange, carbon in grey, hydrogen in white) 
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significantly align with these interests. Our future efforts will be directed toward investigating 
any planarization of these chromene products, and to find their potential application in electronic 
systems.  
UV/Visible Spectrophotometric Analysis 
 Our synthesized phenyl-substituted 6H-naptho[2,1-c]chromenes strongly relate to the 
photochromic compounds described in the introduction, and similar biarylpyrans systems 
(Figure 9, Page 10) display significant UV/Visible spectrophotometric characteristics.13, 15, 16 
Research by Shi and coworkers as well as Burnham and coworkers show the reversible 
conversions of these molecules’ chemical transformations.13, 15  
Both research groups have proposed a 1,1’-biaryl quinone methide intermediate is 
produced when excited with UV light (Figure 9).13, 15 This intermediate has the pyran ring 
opening through the breaking of a carbon-oxygen sigma bond in a conrotatory electrocyclic 
rearrangement (Figure 9).13, 15 These compounds then thermally relax to their “ground state” 
with pyran ring closure (Figure 9).13, 15 However, 
excitation of these biaryl systems in the presence of water 
causes a hydration of the 1,1’-biaryl quinone methide 
tautomer to a dihydroxyl compound (Figure 26).13, 15 
Figure 26: Hydration of biarylpyrans 
system to dihydroxyl compound 
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Our efforts were to similarly investigate the photochromic properties of our 6H-
naptho[2,1-c]chromenes by UV/Visible spectrophotometry. We subjected 11, 6-(4-
bromophenyl)-6H-naptho[2,1-c]chromene, to these absorbance experiments, and propose a 
similar mechanistic process to similar biarylpyrans for its excitation and relaxation (Figure 27).  
Compound 11 displayed an absorbance maximum (λmax) of 245nm and there is also a significant 
absorbance around 325nm in a solution of 1:1 acetonitrile to water (Figure 28). These results 
correlate to previous experimentation by Shi and coworkers.13  
To investigate the tautomer and the transformation of 11, we exposed a sample to 254nm 
light for five minutes and measured its absorbance for multiple hours afterward in a solution of 
Figure 28: Absorption spectrum of 11 (“ground state” absorbance is the solid line, tautomer absorbance 
is the dashed line) 
Figure 27: Proposed photochromic process of 11 
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1:1 acetonitrile to water. We saw a significant change in its absorbance as well as a moderate 
relaxation to the “ground state” (Figure 28). However, this photochemical process was observed 
to be not fully reversed after several hours. This is due in part to the hydration of 11 to a 
dihydroxyl compound in the presence of water. Furthermore, we may have exposed the 
compound to too much UV radiation, causing the molecule to degrade. Understanding the 
photochemistry of chromenes like 11-13 will require more extensive research in a variety of 
















 The efficient synthesis of phenyl-substituted 6H-naptho[2,1-c]chromenes from 2-(3-
hydroxy-4-phenylbut-1-yn-1-yl)phenol and para-substituted benzaldehydes have shown the 
potential of the alkynyl-Prins cyclization as a viable methodology for a novel approach to 
interesting biarylpyran systems for usage in electronic systems, and expanded the scope of past 
research by Hinkle and coworkers. The synthesized chromene products 11-15 display mild 
photochromic and fascinating structural properties, emphasizing their value as potentially useful 
compounds for commercial products like optical triggers, liquid crystals, and camera filters. 
Further efforts will be placed on synthesizing more substrates using the methods described 
herein, optimizing the generation of starting material to streamline the synthetic procedure, and 













Materials and Methods 
All reactions were carried out under argon gas unless otherwise noted. Dichloromethane 
was distilled from CaH2, THF was purified by a LC Technology Solutions Solvent Purification 
System, and both triethylamine and methanol were purchased from ACROS Organics. Other 
chemical materials and solvents were purchased from Oakwood Chemical, Sigma-Aldrich, or 
ACROS Organics. Flash column chromatography was performed using Sorbent Technologies 
40-75μm silica gel (200x400 mesh). Thin layer chromatography was conducted using Sorbent 
Technologies general-purpose silica gel HL TLC plates on glass. Visualization was 
accomplished with UV light or by heating plates dipped in cerium ammonium molybdate (CAM) 
or potassium permanganate staining solutions. Single crystal determinations were carried out 
with a Bruker SMART Apex II diffractometer using graphite-monochromated Cu Kα radiation. 
1H NMR spectra were recorded on a Varian Mercury FTNMR (400 MHz) spectrometer and are 
reported in ppm using solvent as an internal standard (tetramethylsilane at 0.00 ppm or CHCl3 at 
7.27 ppm). Proton-decoupled 13C-NMR spectra were recorded on a Varian Mercury FTNMR 
(400 MHz) spectrometer and are reported in ppm using solvent or TMS as internal standards 
(77.23 ppm for CDCl3 and 0.00 ppm for TMS). Quaternary carbons (C) and methylene carbons 
(CH2) are listed as (e), and methyl carbons (CH3) and methine carbons (CH) are listed as (o). Gas 
chromatography–mass spectrometry (GC-MS) analyses were performed using an Agilent 





Synthesis of 2-((trimethylsilyl)ethynyl)phenol (1) and 2-ethynylphenol (2).  
These syntheses follow the procedures of Arcadi and coworkers.32 
Synthesis of triethyl(2-ethynylphenoxy)silane (3).  
2-Ethynylphenol (2) (1.14 g, 9.66 mmol, 1.0 equiv.) was mixed with imidazole (0.97 g, 14.49 
mmol, 1.5 equiv.) in 17.5 mL of dry CH2Cl2 under argon. Next, chlorotriethylsilane (1.95 mL, 
11.59 mmol, 1.2 equiv.) was added, and the solution was stirred at rt for 1 h. The reaction was 
quenched using saturated NaHCO3, and extracted with 3 x 50 mL of CH2Cl2. The combined 
organic layers were dried using MgSO4 and concentrated in vacuo. The light-yellow liquid was 
purified by column chromatography using a gradient from 100% hexanes to 9:1 hexanes to ethyl 
acetate mixture. This afforded 1.68 g (78% yield) of a yellow liquid.  
1H NMR (CDCl3, 400 MHz): δ=7.42 (dd, J=7.8 Hz, 1.8 Hz, 1 H), 7.19 (td, J=8.2 Hz, 1.8 Hz, 1 
H), 6.89 (td, J=7.8 Hz, 1.2 Hz, 1H), 6.82 (dd, J=8.2 Hz, 1.2 Hz, 1 H), 3.18 (s, 1 H), 1.01 (t, J=7.8 
Hz, 9 H), 0.79 (q, J=7.8 Hz, 6 H) 
13C NMR (APT, CDCl3, 100 MHz): δ=157.4 (e), 134.1 (o), 130.1 (o), 121.3 (o), 119.9 (o), 114.9 
(e), 80.9 (e), 6.8 (o), 5.5 (e) 
Synthesis of 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol (4).  
Diisopropylamine (0.64 mL, 4.59 mmol, 1.0 equiv.) was dissolved in 10.0 mL dry 
tetrahydrofuran and cooled to –78°C under argon. n-Butyllithium (1.84 mL, 4.59 mmol, 1.0 
equiv.) was added dropwise to the solution. Then, triethyl(2-ethynylphenoxy)silane (3) (1.02 g, 
4.59 mmol, 1.0 equiv.) was added to the cool mixture as a solution in 2.0 mL dry 
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tetrahydrofuran. The solution was stirred for 1 h before phenylacetalaldehyde (0.51 mL, 4.59 
mmol, 1.0 equiv.) was added. The solution was allowed to warm to rt and stirred for another 1 h 
under argon. The reaction was quenched using saturated NH4Cl, and extracted with 3 x 20 mL of 
Et2O. The combined organic layers were dried using MgSO4, and concentrated in vacuo. The 
substance was purified by column chromatography using an 8:2 solution of hexanes to ethyl 
acetate. This afforded 0.12 g (11% yield) of a white solid. 
1H NMR (CDCl3, 400 MHz): δ=7.28 (m, 7 H), 6.91 (dd, J=8.2 Hz, 0.8 Hz, 1 H), 6.83 (td, J=7.4 
Hz, 0.8 Hz, 1 H), 6.08 (s, 1 H), 4.85 (t, J=6.3 Hz, 1 H), 3.09 (d, J=6.3 Hz, 2 H), 2.61 (s, 1 H)  
13C NMR (APT, CDCl3, 100 MHz): δ=157.1 (e), 136.5 (e), 132.0 (o), 130.9 (o), 129.9 (o), 128.9 
(o), 127.5 (o), 120.5 (o), 115.1 (o), 108.9 (e), 80.7 (e), 64.0 (o), 44.1 (e) 
Synthesis of tert-butyl(2-ethynylphenoxy)dimethylsilane (5).  
2-Ethynylphenol (2) (0.90 g, 7.62 mmol, 1.0 equiv.) and imidazole (0.78 g, 11.43 mmol, 1.5 
equiv.) were dissolved in 10.0 mL of dry CH2Cl2 under argon. Next, tert-
butyl(chloro)dimethylsilane (9.14 mL, 9.14 mmol, 1.2 equiv.) was added, and the solution was 
stirred for 1 h. The reaction was quenched using saturated NaHCO3, and extracted with 3 x 20 
mL CH2Cl2. The combined organic layers were dried using MgSO4 and concentrated in vacuo. 
The light-yellow liquid was purified by column chromatography using a gradient from 100% 
hexanes to 9:1 hexanes to ethyl acetate mixture. This afforded 1.52 g (92% yield) of a yellow 
liquid.  
Synthesis of 4-(2-((tert-butyldimethylsilyl)oxy)phenyl)-1-phenylbut-3-yn-2-ol (6).  
tert-Butyl(2-ethynylphenoxy)dimethylsilane (5) (0.99 g, 4.58 mmol, 1.0 equiv.) was dissolved in 
10.0 mL of dry tetrahydrofuran and cooled to –78°C under argon. n-Butyllithium (1.89 mL, 4.35 
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mmol, 0.95 equiv.) was added dropwise to the cooled solution and allowed to stir for 1 h. 
Phenylacetalaldehyde (0.49 mL, 4.35 mmol, 0.95 equiv.) was added, and the solution was 
allowed to warm to rt and stir for another 1 h under argon. The reaction was quenched using 
saturated NH4Cl, and extracted with 3 x 20 mL Et2O. The combined organic layers were dried 
using MgSO4, and concentrated in vacuo. The red residue was purified by column 
chromatography using an 8:2 solution of hexanes to ethyl acetate. This afforded 0.59 g (40% 
yield) of a white solid. 
1H NMR (CDCl3, 400 MHz): δ=7.33 (d, J=1.6 Hz, 1 H), 7.32 (d, J=4.7 Hz, 5 H), 7.26 (dd, J=8.6 
Hz, 4.1 Hz, 1 H), 7.18 (td, J=7.8 Hz, 1.5 Hz, 1 H), 6.87 (td, J=7.4 Hz, 1.2 Hz, 1 H), 6.80 (dd, 
J=8.2 Hz, 0.8 Hz, 1 H), 4.80 (t, J=6.6 Hz, 1 H), 3.10 (dd, J=8.6 Hz, 5.9 Hz, 2 H), 1.02 (s, 9 H), 
0.21 (s, 6 H) 
13C NMR (APT, CDCl3, 100 MHz): δ=156.7 (e), 137.0 (e), 133.8 (o), 130.0 (o), 129.8 (o), 128.6 
(o), 127.1 (o), 121.3 (o), 119.9 (o), 115.2 (e), 93.1 (e), 83.3 (e), 64.1 (o), 44.6 (e), 25.9 (o), 18.5 
(e), -4.1 (o) 
Synthesis of 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol (4) from 4-(2-((tert-
butyldimethylsilyl)oxy)phenyl)-1-phenylbut-3-yn-2-ol (6).  
4-(2-((tert-Butyldimethylsilyl)oxy)phenyl)-1-phenylbut-3-yn-2-ol (6) (0.35 g, 1.10 mmol, 1.0 
equiv.) was dissolved in 7 mL of dry tetrahydrofuran under argon. Then, TBAF 
(tetrabutylammonium fluoride) (1.65 mL, 1.65 mmol, 1.5 equiv.) was added to the cooled 
solution, and the mixture was allowed to warm to rt and stir for 1 h. The reaction was diluted 
with tetrahydrofuran, dried with MgSO4, and concentrated in vacuo. The substance was purified 
38 
 
by column chromatography using a 7:3 solution of hexanes to ethyl acetate. This afforded 0.22 g 
(85% yield) of a white solid. 
1H NMR (CDCl3, 400 MHz): δ=7.28 (m, 7 H), 6.91 (dd, J=8.2 Hz, 0.8 Hz, 1 H), 6.83 (td, J=7.4 
Hz, 0.8 Hz, 1 H), 6.08 (s, 1 H), 4.85 (t, J=6.3 Hz, 1 H), 3.09 (d, J=6.3 Hz, 2 H), 2.61 (s, 1 H)  
13C NMR (APT, CDCl3, 100 MHz): δ=157.1 (e), 136.5 (e), 132.0 (o), 130.9 (o), 129.9 (o), 128.9 
(o), 127.5 (o), 120.5 (o), 115.1 (o), 108.9 (e), 80.7 (e), 64.0 (o), 44.1 (e) 
Synthesis of 1-phenyl-4-(trimethylsilyl)but-3-yn-2-ol (7) and 1-phenylbut-3-yn-2-ol (8).  
These syntheses follow the procedures of Hinkle and coworkers.3, 4 
Synthesis of triethyl(2-iodophenoxy)silane (9).  
2-Iodophenol (1.0 g, 4.55 mmol, 1,0 equiv.) was dissolved in 15.0 mL dry CH2Cl2. Imidazole 
(0.87 g, 12.17 mmol, 1.5 equiv.), and then chlorotriethylsilane (1.71 mL, 10.17 mmol, 1.2 
equiv.) were added to the solution. The solution was stirred for 1 h under argon, and then 
quenched using saturated NaHCO3, and extracted with 3 x 30 mL CH2Cl2. The combined organic 
layers were dried over MgSO4 and concentrated in vacuo. The yellow liquid was purified by 
column chromatography using a 9:1 solution of hexanes to ethyl acetate. This afforded 1.41 g 
(93% yield) of a white solid. 
Synthesis of 1-phenyl-4-(2-((triethylsilyl)oxy)phenyl)but-3-yn-2-ol (10).  
Triethyl(2-iodophenoxy)silane (9) (0.12 g, 0.35 mmol, 0.69 equiv.) was dissolved in 2.0 mL of 
triethylamine. Next, Pd(OAc)2 (5.6 mg, 0.025 mmol, 0.05 equiv.), triphenylphosphine (13.4 mg, 
0.051 mmol, 0.1 equiv.), and copper iodide (4.8 mg, 0.025 mmol, 0.05 equiv.) were added to the 
solution. The solution was de-gassed in vacuo using a high vacuum pump system. 1-Phenylbut-
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3-yn-2-ol (8) (74.0 mg, 0.51 mmol, 1.0 equiv.) was added to the solution and it was stirred for 16 
h under argon. The reaction was quenched using saturated NH4Cl and extracted using 3 x 30 mL 
ethyl acetate and saturated NaCl. The brown residue was dried using MgSO4 and concentrated in 
vacuo. The substance was purified by column chromatography using a 7:3 solution of hexanes to 
ethyl acetate. This afforded 64.0 mg (51% yield) of a brown liquid. 
Synthesis of 6-(4-bromophenyl)-6H-naptho[2,1-c]chromene (11).  
4-Bromobenzaldehyde (21.5 mg, 0.116 mmol, 1.1 equiv.) was dissolved in 1.0 mL dry CH2Cl2 
with 8 molecular sieves under argon. The solution was cooled to –78°C and BF3·OEt2 (22.0 µL, 
0.210 mmol, 2.0 equiv.) was added dropwise. Next, 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol 
(4) (25.0 mg, 0.105 mmol, 1.0 equiv.) was added to the cooled mixture in a solution of 1.0 mL 
dry CH2Cl2. The mixture was allowed to warm to rt as it stirred for 5 h. The reaction was 
quenched using saturated NaHCO3, and extracted with 5 x 5.0 mL CH2Cl2. The extracted organic 
layers were dried over MgSO4 and concentrated in vacuo. The light-yellow residue was purified 
by column chromatography using a 1:1 solution of hexanes to dichloromethane. This afforded 
28.5 mg (70% yield) of a white solid. 
1H NMR (CDCl3, 400 MHz): δ=8.62 (d, J=8.2 Hz, 1 H), 8.02 (dd, J=7.8 Hz, 1.6 Hz, 1 H), 7.88 
(d, J=8.6 Hz, 1 H), 7.73 (d, J=8.2 Hz, 1 H), 7.54 (m, 2 H), 7.43 (dt, J=8.6 Hz, 2.4 Hz, 2 H), 7.23 
(m, 3 H), 7.10 (m, 2 H), 7.01 (d, J=8.2 Hz, 1 H), 6.13 (s, 1 H) 
13C NMR (APT, CDCl3, 100 MHz): δ=154.7 (e), 138.2 (e), 134.4 (e), 131.8 (o), 130.3 (o), 129.3 
(e), 129.2 (o), 129.1 (o), 128.3 (o), 128.2 (o), 127.5 (e), 127.2 (o), 126.2 (o), 125.7 (o), 124.1 (e), 
123.7 (o), 122.8 (e), 122.2 (o), 118.7 (o), 80.3 (o) 
Synthesis of 6-(4-chlorophenyl)-6H-naptho[2,1-c]chromene (12).  
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4-Chlorobenzaldehyde (16.3 mg, 0.116 mmol, 1.1 equiv.) was dissolved in 1.0 mL dry CH2Cl2 
with 8 molecular sieves under argon. The solution was cooled to –78°C and BF3·OEt2 (22.0 µL, 
0.210 mmol, 2.0 equiv.) was added dropwise. Next, 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol 
(4) (25.0 mg, 0.105 mmol, 1.0 equiv.) was added to the cooled mixture in a solution of 0.5 mL 
dry CH2Cl2. The mixture was allowed to warm to rt as it stirred for 5 h. The reaction was 
quenched using saturated NaHCO3 and extracted with 3 x 5.0 mL CH2Cl2. The extracted organic 
layers were dried over MgSO4 and concentrated in vacuo. The light-yellow residue was purified 
by column chromatography using a 1:1 solution of hexanes to dichloromethane. This afforded 
33.0 mg (92% yield) of a white solid. 
1H NMR (CDCl3, 400 MHz): δ=8.64 (d, J=8.6 Hz, 1 H), 8.37 (dd, J=7.8 Hz, 1.6 Hz, 1 H), 7.90 
(d, J=8.2 Hz, 1 H), 7.75 (d, J=8.2 Hz, 1 H), 7.55 (m, 2 H), 7.26 (m, 5 H), 7.12 (m, 2 H), 7.02 (d, 
J=8.6 Hz, 1 H), 6.17 (s, 1 H) 
13C NMR (APT, CDCl3, 100 MHz): δ=154.8 (e), 137.7 (e), 134.6 (e), 134.5 (e), 134.4 (e), 130.0 
(o), 129.3 (e), 129.2 (o), 129.1 (o), 128.9 (o), 128.3 (o), 128.2 (o), 127.5 (e), 127.2 (o), 126.2 (o), 
125.7 (o), 124.2 (e), 123.7 (o), 122.2 (o), 118.7 (o), 80.3 (o)  
Synthesis of 6-(p-tolyl)-6H-naptho[2,1-c]chromene (13).  
p-Tolualdehyde (13.72 µL, 0.116 mmol, 1.1 equiv.) was dissolved in 1.0 mL dry CH2Cl2 with 8 
molecular sieves under argon. The solution was cooled to –78°C and BF3·OEt2 (22.0µL, 0.210 
mmol, 2.0 equiv.) was added dropwise. Next, 2-(3-hydroxy-4-phenylbut-1-yn-1-yl)phenol (4) 
(25.0 mg, 0.105 mmol, 1.0 equiv.) was added to the cooled mixture in a solution of 0.5 mL dry 
CH2Cl2. The mixture was allowed to warm to rt as it stirred for 5 h. The reaction was quenched 
using saturated NaHCO3 and extracted with 3 x 5.0 mL CH2Cl2. The extracted organic layers 
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were dried over MgSO4 and concentrated in vacuo. The light-yellow residue was purified by 
column chromatography using a 1:1 solution of hexanes to dichloromethane. This afforded 3.9 
mg (1% yield) of a white substance. 
1H NMR (CDCl3, 400 MHz): δ=8.64 (d, J=8.6 Hz, 1 H), 8.04 (dd, J=7.4 Hz, 1.2 Hz, 1 H), 7.88 
(d, J=8.6 Hz, 1 H), 7.72 (d, J=8.6 Hz, 1 H), 7.55 (m, 2 H), 7.25 (m, 3 H), 7.12 (m, 4 H), 7.02 (d, 
J=8.6 Hz, 1 H), 6.15 (s, 1 H), 2.34 (s, 3 H) 
13C NMR (APT, CDCl3, 100 MHz): δ=155.2 (e), 138.5 (e), 136.1 (e), 135.4 (e), 134.5 (e), 129.4 
(o), 129.2 (e), 129.1 (o), 129.0 (o), 128.7 (o), 128.1 (o), 128.0 (o), 127.5 (e), 127.0 (o), 126.0 (o), 
125.8 (o), 124.3 (e), 123.9 (o), 121.9 (o), 118.6 (o), 81.1 (o), 21.4 (o) 
Synthesis of 6-(4-nitrophenyl)-6H-naptho[2,1-c]chromene (14).  
4-Nitrobenzaldehyde (48.4 mg, 0.32 mmol, 1.1 equiv.) was dissolved in 2.0 mL dry CH2Cl2 with 
8 molecular sieves under argon. The solution was cooled to –78°C and BF3·OEt2 (60.0 µL, 0.58 
mmol, 2.0 equiv.) was added dropwise. Next, 1-phenyl-4-(2-((triethylsilyl)oxy)phenyl)but-3-yn-
2-ol (10) (102.5 mg, 0.29 mmol, 1.0 equiv.) was added to the cooled mixture in a solution of 1.0 
mL dry CH2Cl2. The mixture was allowed to warm to rt as it stirred for 5 h. The reaction was 
quenched using saturated NaHCO3 and extracted with 3 x 5.0 mL CH2Cl2. The extracted organic 
layers were dried over MgSO4 and concentrated in vacuo. The light-yellow residue was purified 
by column chromatography using a 1:1 solution of hexanes to dichloromethane. This afforded 
<1.0 mg (<1% yield) of an off-white substance. 
Synthesis of 6-(4-(trifluoromethyl)phenyl)-6H-naptho[2,1-c]chromene (15).  
α,α,α-Trifluoro-p-tolualdehyde (9.80µL, 0.07 mmol, 1.1 equiv.) was dissolved in 2.0 mL dry 
CH2Cl2 with 8 molecular sieves under argon. The solution was cooled to –78°C and BF3·OEt2 
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(13.6µL, 0.13 mmol, 2.0 equiv.) was added dropwise. Next, 1-phenyl-4-(2-
((triethylsilyl)oxy)phenyl)but-3-yn-2-ol (10) (23.0 mg, 0.065 mmol, 1.0 equiv.) was added to the 
cooled mixture in a solution of 1.0 mL dry CH2Cl2. The mixture was allowed to warm to rt as it 
stirred for 5 h. The reaction was quenched using saturated NaHCO3 and extracted with 3 x 5.0 
mL CH2Cl2. The extracted organic layers were dried over MgSO4 and concentrated in vacuo. 
The light-yellow residue was purified by column chromatography using a 1:1 solution of 
















1. Han, Xun; Peh, GuangRong; Floreancig, Paul E. “Prins-Type Cyclization Reactions in 
Natural Product Synthesis.” Eur. J. Org. Chem. 2013, 1193-1208. 
2. Pastor, Isidro M.; Yus, Miguel. “Focused Update on the Prins Reaction and the Prins 
Cyclization.” Current Organic Chemistry. 2012, 16, 1277-1312. 
3. Hinkle, Robert J.; Lewis, Shane E. “Atom Economical, One-Pot, Three-Reaction Cascade 
to Novel Tricyclic 2,4-Dihydro-1H-benzo[f]isochromenes.” Org. Lett. 2013, 15, 4070-
4073. 
4. Hinkle, Robert J.; Chen, Yuzhou; Nofi, Colleen P.; Lewis, Shane E. “Electronic effects 
on a one-pot aromatization cascade involving alkynyl-Prins cyclization, Friedel–Crafts 
alkylation and dehydration to tricyclic benzo[f]isochromenes.” Org. Biomol. Chem. 2017, 
15, 7584-7593. 
5. Subba Reddy, B. V.; Jala, Sayed; Borkar, Prashant; Yadav, J. S.; Reddy, P. P.; Kunwar, 
A. C.; Sridhar, B. “The stereoselective synthesis of cis-/trans-fused 
hexahydropyrano[4,3-b]-chromenes via Prins cyclization trapping by a tethered 
nucleophile.” Org. Biomol. Chem. 2012, 10, 6562-6568. 
6. Yadav, J. S.; Subba Reddy, B. V.; Ganesh, A. V.; Narayana Kumar, G. G. K. S. 
“Sc(OTf)3-catalyzed one-pot ene-Prins cyclization: a novel synthesis of octahydro-2H-
chromen-4-ols.” Tett. Lett. 2010, 51, 2963-2966. 
7. Qing, Xushun; Wang, Ting; Dal, Chenlu; Su, Zhenjie; Wang, Cunde. “Direct Synthesis 
of 6H-Chromeno[3,4-b]quinoline-6-ol Derivatives from Substituted 3-Nitro-2H-
Chromenes and 2-Nitrobenzaldehydes Mediated by Fe/AcOH System.” Synthesis. 2018, 
50, 1350-1358. 
8. Lee, Hong Myung; Nieto-Oberhuber, Cristina; Shair, Matthew D. “Enantioselective 
Synthesis of (+)-Cortistatin A, a Potent and Selective Inhibitor of Endothelial Cell 
Proliferation.” J. Am. Chem. Soc. 2008, 130, 16864-16866. 
9. Marumoto, Shinji; Jaber, James J.; Vitale, Justin P.; Rychnovsky, Scott D. “Synthesis of 
(−)-Centrolobine by Prins Cyclizations that Avoid Racemization.” Org. Lett. 2002, 4, 
3919-3922. 
10. MacMillan, David W. C.; Overman, Larry E. “Enantioselective Total Synthesis of (−)-7-
Deacetoxyalcyonin Acetate. First Synthesis of a Eunicellin Diterpene.” J. Am. Chem. 
Soc. 1995, 117, 10391-10392. 
11. Crano, John C.; Guglielmetti, Robert J. Organic Photochromic and Thermochromic 
Compounds; Kluwer Academic Publishers: New York, Boston, Dordrecht, London, 
Moscow, 2002. 
12. Gemert, Barry Van. “Benzo and Napthopyrans (Chromenes).” In Organic Photochromic 
and Thermochromic Compounds; Crano, John C., Guglielmetti, Robert J.; Kluwer 
Academic Publishers: New York, Boston, Dordrecht, London, Moscow, 2002; Vol. 1; p 
111-137.  
13. Shi, Yijian; Wan, Peter. “Photocyclization of a 1,1’-bisnapthalene: planarization of a 
highly twisted biaryl system after excited state ArOH dissociation.” Chem. Comm. 1997, 
3, 273-274. 
14. Wang, Bin; Li, Minxiong; Xu, Shansheng; Song, Haibin; Wang, Baiquan. “Synthesis and 
Structures of 1,1’-Dinapthopyrans.” Synthesis. 2007, 9, 1304-1308. 
44 
 
15. Burnham, Kikue, S.; Schuster, Gary B. “A Search for Chiral Photochromic Optical 
Triggers for Liquid Crystals: Photoracemization of 1,1’-Binapthopyrans through a 
Transient Biaryl Quinone Methide Intermediate.” J. Am. Chem. Soc. 1998, 120, 12619-
12625. 
16. Kumar, Satish; Hernandez, David; Hoa, Brenda; Lee, Yuna; Yang, Julie S.; McCurdy, 
Allison. “Synthesis, Photochromic Properties, and Light-Controlled Metal Complexation 
of a Napthopyran Derivative.” Org. Lett. 2008, 10, 3761-3764. 
17. Rastogi, Shiva K.; Medellin, Derek C.; Kornienko, Alexander. “C–H functionalization 
directed by transformable nitrogen heterocycles: synthesis of ortho-oxygenated 
arylnaphthalenes from arylphthalazines.” Org. Biomol. Chem. 2014, 12, 410-413. 
18. Storch, Jan; Bernard, Martin; Sýkora, Jan; Karban, Jindřich; Cˇermák, Jan. 
“Intramolecular Cascade Hydroarylation/Cycloisomerization Strategy for the Synthesis 
of Polycyclic Aromatic and Heteroaromatic Systems.” Eur. J. Org. Chem. 2013, 260-263. 
19. Mechoulam, Raphael; Hanuš, Lumír. “A Historical Overview of Chemical Research on 
Cannabinoids.” Chem. Phys. Lipids. 2000, 108, 1-13. 
20. Khanolkar, Atmaram D.; Lu, Dai; Ibrahim, Mohab; Duclos, Richard I., Jr.; Thakur, 
Ganesh A.; Malan, T. Phillip, Jr.; Porreca, Frank; Veerappan, Vijayabaskar; Tian, 
Xiaoyu; George, Clifford; Parrish, Damon A.; Papahatjis, Demetris P.; Makriyannis, 
Alexandros. Cannabilactones: A Novel Class of CB2 Selective Agonists with Peripheral 
Analgesic Activity. J. Med. Chem. 2007, 50, 6493-6500. 
21. Chang, Chia-en A.; Ai, Rizi; Gutierrez, Michael; Marsella, Michael J. “Homology 
modeling of cannabinoid receptors: discovery of cannabinoid analogues for therapeutic 
use.” Methods in Molecular Biology. 2012. 819, 595-613. 
22. Aso, Ester; Ferrer, Isidre. “Cannabinoids for Treatment of Alzheimer's disease: Moving 
toward the Clinic.” Front. in Pharm. 2014, 37, 1-11. 
23. Sinal, Alon; Turner, Ziv. “Novel Cannabinoid Combination Therapies for Multiple 
Myeloma (MM).” WO 2016199148 A1, December 15, 2016. 
24. Chen, Tianrui; Hu, Chengyue. “Application of full cannabinoid in preparation of 
pharmaceutical formulation for preventing and treating senile dementia.” CN 2016-
105943619 A, September 21, 2016. 
25. Guy, Geoffrey; Wright, Stephen; Mead, Alice; Cheetham, Emma; Devinsky, Orrin; 
Schiller, Dominic. “Use of cannabinoids in the treatment of epilepsy.” WO 2016203239 
A1, December 22, 2016. 
26. Fraguas-Sanchez, A. I.; Fernandez-Carballido, A.; Torres-Suarez, A. I. “Phyto-, endo- 
and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast 
and prostate carcinomas.” Expert Opin. Investig. Drugs. 2016, 25, 1311-1323. 
27. Rice, Andrew Sc. “Cannabinoids and Pain.” Curr. Opin. Investig. Drugs. 2001, 2, 399-
414. 
28. Hua, Tian; Vemuri, Kiran; Pu, Mengchen; Qu, Lu; Han, Gye Won; Wu, Yiran; Zhao, 
Suwen; Shui, Wenqing; Li, Shanshan; Korde, Anisha; Laprairie, Robert B.; Stahl, 
Edward L.; Ho, Jo-Hao; Zvonok, Nikolai; Zhou, Han; Kufareva, Irina; Wu, Beili; Zhao, 
Qiang; Hanson, Michael A.; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, 
Raymond C.; Liu, Zhi-Jie. “Crystal Structure of the Human Cannabinoid Receptor CB1.” 
Cell. 2016, 167, 750-762. 
29. Husni, Sfeef S.; McCurdy, Christopher R.; Radwan, Mohamed M.; Ahmed, Safwat A.; 
Slade, Desmond; Ross, Samir A.; ElSohly, Mahmoud A.; Cutler, Stephen J. “Evaluation 
45 
 
of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to 
Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid 
Receptor 2.” Med. Chem. Res. 2013, 23, 4295-4300. 
30. Galal, Ahmed M.; Slade, Desmond; Gul, Waseem; El-Alfy, Abir T.; Ferreira, Daneel; 
Elsohly, Mahmoud A. “Naturally Occurring and Related Synthetic Cannabinoids and 
their Potential Therapeutic Applications.” Recent Patents on CNS Drug Discovery. 2009, 
4, 112-136. 
31. Sun, Song; Wang, Bingbing; Gu, Ning; Yu, Jin-Tao; Cheng, Jiang. “Palladium-Catalyzed 
Arylcarboxylation of Propargylic Alcohols with CO2 and Aryl Halides: Access to 
Functionalized α-Alkylidene Cyclic Carbonates.” Org. Lett. 2017, 19, 1088-1091. 
32. Arcadi, Antonio; Cacchi, Sandro; Rosario, Mario Del; Fabrizi, Giancarlo; Marinelli, 
Fabio. “Palladium-Catalyzed Reaction of o-Ethynylphenols, o-
((Trimethylsilyl)ethynyl)phenyl Acetates, and o-Alkynylphenols with Unsaturated 
Triflates or Halides: A Route to 2-Substituted-, 2,3-Disubstituted-, and 2-Substituted-3-























All 1H, APT, 13C, gCOSY, and HSQC NMR spectra for each compound listed above are 
attached. The HSQC spectrum for 4-(2-((tert-butyldimethylsilyl)oxy)phenyl)-1-phenylbut-3-yn-
2-ol (6) was not acquired. 
 








X-ray Crystal Data and Structure Refinement for 11  
Identification code  11 
Empirical formula  C23 H15 Br O 
Formula weight  387.26 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 11.298(3) Å = 90°. 
 b = 15.006(3) Å = 100.360(4)°. 
 c = 9.832(2) Å  = 90°. 
Volume 1639.7(6) Å3 
Z 4 
Density (calculated) 1.569 Mg/m3 
Absorption coefficient 2.514 mm-1 
F(000) 784 
Crystal size 0.500 x 0.320 x 0.080 mm3 
Theta range for data collection 1.832 to 26.080°. 
Index ranges -13<=h<=13, -18<=k<=18, -11<=l<=12 
Reflections collected 24765 
Independent reflections 3229 [R(int) = 0.0234] 
Completeness to theta = 25.242° 100.0 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3229 / 0 / 226 
Goodness-of-fit on F2 1.067 
Final R indices [I>2sigma(I)] R1 = 0.0214, wR2 = 0.0580 
R indices (all data) R1 = 0.0236, wR2 = 0.0592 
Extinction coefficient n/a 
Largest diff. peak and hole 0.372 and -0.268 e.Å-3 
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 Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for 11.res. U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
Br(1) 713(1) 6869(1) 3310(1) 21(1) 
O(1) 5452(1) 5670(1) 8141(1) 16(1) 
C(1) 5662(1) 6247(1) 7018(2) 14(1) 
C(2) 6263(1) 7098(1) 7616(2) 13(1) 
C(3) 5994(1) 7926(1) 6955(2) 14(1) 
C(4) 6589(1) 8679(1) 7478(2) 15(1) 
C(5) 7429(1) 8647(1) 8732(2) 14(1) 
C(6) 8002(1) 9437(1) 9315(2) 17(1) 
C(7) 8754(2) 9421(1) 10570(2) 19(1) 
C(8) 8942(1) 8617(1) 11315(2) 17(1) 
C(9) 8422(1) 7842(1) 10770(2) 14(1) 
C(10) 7684(1) 7818(1) 9441(2) 13(1) 
C(11) 7133(1) 7024(1) 8798(2) 12(1) 
C(12) 7418(1) 6114(1) 9335(2) 13(1) 
C(13) 8516(1) 5839(1) 10121(2) 15(1) 
C(14) 8657(2) 4987(1) 10676(2) 18(1) 
C(15) 7707(2) 4387(1) 10445(2) 19(1) 
C(16) 6628(2) 4624(1) 9602(2) 18(1) 
C(17) 6509(1) 5469(1) 9024(2) 14(1) 
C(18) 4456(1) 6383(1) 6104(2) 14(1) 
C(19) 4270(1) 6154(1) 4714(2) 16(1) 
C(20) 3161(1) 6298(1) 3865(2) 17(1) 
C(21) 2243(1) 6672(1) 4436(2) 15(1) 
C(22) 2399(2) 6906(1) 5826(2) 18(1) 




 Table 3. Bond lengths [Å] and angles [°] for 11.res. 
____________________________________________________  
Br(1)-C(21)  1.9012(16) 
O(1)-C(17)  1.3777(18) 
O(1)-C(1)  1.4555(17) 
C(1)-C(18)  1.505(2) 
C(1)-C(2)  1.514(2) 
C(1)-H(1)  1.0000 
C(2)-C(11)  1.385(2) 
C(2)-C(3)  1.410(2) 
C(3)-C(4)  1.367(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.415(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.420(2) 
C(5)-C(10)  1.430(2) 
C(6)-C(7)  1.367(2) 
C(6)-H(6)  0.9500 
C(7)-C(8)  1.408(2) 
C(7)-H(7)  0.9500 
C(8)-C(9)  1.368(2) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.419(2) 
C(9)-H(9)  0.9500 
C(10)-C(11)  1.437(2) 
C(11)-C(12)  1.477(2) 
C(12)-C(13)  1.401(2) 
C(12)-C(17)  1.404(2) 
C(13)-C(14)  1.388(2) 
C(13)-H(13)  0.9500 
C(14)-C(15)  1.388(2) 
C(14)-H(14)  0.9500 
C(15)-C(16)  1.391(2) 
C(15)-H(15)  0.9500 
C(16)-C(17)  1.387(2) 
C(16)-H(16)  0.9500 
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C(18)-C(19)  1.388(2) 
C(18)-C(23)  1.399(2) 
C(19)-C(20)  1.393(2) 
C(19)-H(19)  0.9500 
C(20)-C(21)  1.383(2) 
C(20)-H(20)  0.9500 
C(21)-C(22)  1.392(2) 
C(22)-C(23)  1.386(2) 
C(22)-H(22)  0.9500 




















































































 Table 4. Anisotropic displacement parameters (Å2x 103) for 11.res. The anisotropic 
displacement factor exponent takes the form: -22[ h2 a*2U11 + ...  + 2 h k a* b* U12] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
Br(1) 15(1)  22(1) 23(1)  8(1) -2(1)  1(1) 
O(1) 16(1)  15(1) 16(1)  3(1) 1(1)  -3(1) 
C(1) 17(1)  12(1) 13(1)  1(1) 3(1)  -1(1) 
C(2) 14(1)  13(1) 14(1)  -1(1) 5(1)  -1(1) 
C(3) 14(1)  17(1) 13(1)  2(1) 2(1)  2(1) 
C(4) 17(1)  12(1) 17(1)  4(1) 6(1)  3(1) 
C(5) 14(1)  12(1) 16(1)  0(1) 6(1)  0(1) 
C(6) 20(1)  11(1) 21(1)  1(1) 7(1)  0(1) 
C(7) 19(1)  13(1) 24(1)  -4(1) 4(1)  -3(1) 
C(8) 15(1)  17(1) 18(1)  -2(1) 1(1)  1(1) 
C(9) 14(1)  13(1) 16(1)  1(1) 3(1)  1(1) 
C(10) 11(1)  13(1) 16(1)  0(1) 5(1)  0(1) 
C(11) 13(1)  12(1) 13(1)  0(1) 5(1)  0(1) 
C(12) 17(1)  12(1) 11(1)  0(1) 5(1)  1(1) 
C(13) 16(1)  14(1) 16(1)  -1(1) 4(1)  1(1) 
C(14) 20(1)  16(1) 17(1)  1(1) 3(1)  5(1) 
C(15) 29(1)  12(1) 18(1)  2(1) 6(1)  4(1) 
C(16) 23(1)  13(1) 17(1)  -2(1) 4(1)  -3(1) 
C(17) 17(1)  14(1) 12(1)  -2(1) 3(1)  1(1) 
C(18) 15(1)  11(1) 16(1)  0(1) 2(1)  -2(1) 
C(19) 16(1)  15(1) 17(1)  -1(1) 4(1)  -1(1) 
C(20) 20(1)  17(1) 13(1)  0(1) 2(1)  -2(1) 
C(21) 13(1)  12(1) 18(1)  4(1) -1(1)  -2(1) 
C(22) 18(1)  17(1) 20(1)  0(1) 6(1)  2(1) 




 Table 5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 10 3) 
for 11.res. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1) 6208 5934 6477 17 
H(3) 5396 7961 6143 17 
H(4) 6437 9228 6997 18 
H(6) 7859 9983 8826 20 
H(7) 9149 9951 10937 22 
H(8) 9435 8612 12207 20 
H(9) 8559 7308 11293 17 
H(13) 9175 6241 10276 18 
H(14) 9406 4814 11215 21 
H(15) 7793 3815 10863 23 
H(16) 5981 4211 9424 21 
H(19) 4908 5897 4337 19 
H(20) 3036 6143 2913 20 
H(22) 1758 7162 6201 21 










































































 Table 7.  Hydrogen bonds for 11.res [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
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